|
1
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics. CA Cancer J Clin. 60:277–300. 2010.
|
|
2
|
Wood LD, Parsons DW, Jones S, et al: The
genomic landscape of human breast and colorectal cancers. Science.
318:1108–1113. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Jones PA and Baylin SB: The fundamental
role of epigenetic events in cancer. Nat Rev Genet. 3:415–428.
2002.PubMed/NCBI
|
|
4
|
Jones PA and Baylin SB: The epigenomics of
cancer. Cell. 128:683–692. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Iida S, Akiyama Y, Nakajima T, Ichikawa W,
Nihei Z, Sugihara K and Yuasa Y: Alterations and hypermethylation
of the p14ARF gene in gastric cancer. Int J Cancer. 87:654–658.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Samuels Y, Wang Z, Bardelli A, et al: High
frequency of mutations of the PIK3CA gene in human cancers.
Science. 304:5542004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Vogelstein B, Fearon ER, Hamilton SR, et
al: Genetic alterations during colorectal-tumor development. N Engl
J Med. 319:525–532. 1988. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Kato S, Iida S, Higuchi T, et al: PIK3CA
mutation is predictive of poor survival in patients with colorectal
cancer. Int J Cancer. 121:1771–1778. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Eads CA, Danenberg KD, Kawakami K, et al:
MethyLight: a high-throughput assay to measure DNA methylation.
Nucleic Acids Res. 28:E32–00. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shimizu S, Iida S, Ishiguro M, et al:
Methylated BNIP3 gene in colorectal cancer prognosis. Oncol Lett.
1:865–872. 2010.PubMed/NCBI
|
|
11
|
Aoyagi H, Iida S, Uetake H, et al: Effect
of classification based on combination of mutation and methylation
in colorectal cancer prognosis. Oncol Rep. 25:789–794.
2011.PubMed/NCBI
|
|
12
|
Ward RL, Cheong K, Ku SL, Meagher A,
O’Connor T and Hawkins NJ: Adverse prognostic effect of methylation
in colorectal cancer is reversed by microsatellite instability. J
Clin Oncol. 21:3729–3736. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shen L, Toyota M, Kondo Y, et al:
Integrated genetic and epigenetic analysis identifies three
different subclasses of colon cancer. Proc Natl Acad Sci USA.
104:18654–18659. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Reed JC: Bcl-2 family proteins. Oncogene.
17:3225–3236. 1998. View Article : Google Scholar
|
|
15
|
Labi V, Erlacher M, Kiessling S and
Villunger A: BH3-only proteins in cell death initiation, malignant
disease and anticancer therapy. Cell Death Differ. 13:1325–1338.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Strasser A: The role of BH3-only proteins
in the immune system. Nat Rev Immunol. 5:189–200. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Willis SN and Adams JM: Life in the
balance: how BH3-only proteins induce apoptosis. Curr Opin Cell
Biol. 17:617–625. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vande VC, Cizeau J, Dubik D, et al: BNIP3
and genetic control of necrosis-like cell death through the
mitochondrial permeability transition pore. Mol Cell Biol.
20:5454–5468. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Mellor HR and Harris AL: The role of the
hypoxia-inducible BH3-only proteins BNIP3 and BNIP3L in cancer.
Cancer Metastasis Rev. 26:553–566. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Murai M, Toyota M, Suzuki H, et al:
Aberrant methylation and silencing of the BNIP3 gene in colorectal
cancer and gastric cancer. Clin Cancer Res. 11:1021–1027.
2005.PubMed/NCBI
|
|
21
|
Akada M, Crnogorac-Jurcevic T, Lattimore
S, et al: Intrinsic chemoresistance to gemcitabine is associated
with decreased expression of BNIP3 in pancreatic cancer. Clin
Cancer Res. 11:3094–3101. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Erkan M, Kleeff J, Esposito I, et al: Loss
of BNIP3 expression is a late event in pancreatic cancer
contributing to chemoresistance and worsened prognosis. Oncogene.
24:4421–4432. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Manka D, Spicer Z and Millhorn DE:
Bcl-2/adenovirus E1B 19 kDa interacting protein-3 knockdown enables
growth of breast cancer metastases in the lung, liver, and bone.
Cancer Res. 65:11689–11693. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Barault L, Veyrie N, Jooste V, et al:
Mutations in the RAS-MAPK, PI(3)K (phosphatidylinositol-3-OH
kinase) signaling network correlate with poor survival in a
population-based series of colon cancers. Int J Cancer.
122:2255–2259. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Manning BD and Cantley LC: AKT/PKB
signaling: Navigating downstream. Cell. 129:1261–1274. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Velho S, Oliveira C, Ferreira A, et al:
The prevalence of PIK3CA mutations in gastric and colon cancer. Eur
J Cancer. 41:1649–1654. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Benvenuti S, Frattini M, Arena S, et al:
PIK3CA cancer mutations display gender and tissue specificity
patterns. Hum Mutat. 29:284–288. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Abubaker J, Bavi P, Al-Harbi S, et al:
Clinicopathological analysis of colorectal cancers with PIK3CA
mutations in Middle Eastern population. Oncogene. 27:3539–3545.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Nosho K, Kawasaki T, Ohnishi M, et al:
PIK3CA mutation in colorectal cancer: relationship with genetic and
epigenetic alterations. Neoplasia. 10:534–541. 2008.PubMed/NCBI
|
|
30
|
Samuels Y, Diaz LA Jr, Schmidt-Kittler O,
et al: Mutant PIK3CA promotes cell growth and invasion of human
cancer cells. Cancer Cell. 7:561–573. 2005. View Article : Google Scholar
|
|
31
|
Ogino S, Nosho K, Kirkner GJ, et al:
PIK3CA mutation is associated with poor prognosis among patients
with curatively resected colon cancer. J Clin Oncol. 27:1477–1484.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Nosho K, Yamamoto H, Takahashi T, et al:
Genetic and epigenetic profiling in early colorectal tumors and
prediction of invasive potential in pT1 (early invasive) colorectal
cancers. Carcinogenesis. 28:1364–1370. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Whitehall V, Rickman C, Bond C, et al:
Oncogenic PIK3CA mutations in colorectal cancers and polyps. Int J
Cancer. 2011.(Epub ahead of print). View Article : Google Scholar
|
|
34
|
Bruin SC, He Y, Mikolajewska-Hanclich I,
et al: Molecular alterations associated with liver metastases
development in colorectal cancer patients. Br J Cancer.
105:281–287. 2011. View Article : Google Scholar : PubMed/NCBI
|
